European Archives - Page 128 of 1345 - European Medical Journal

British government buildings

UK government establishes RNA Biofoundry

A £29.6 million government investment will establish the UK RNA Biofoundry in Darlington, providing manufacturing capacity to accelerate RNA therapies from lab to clinic.

New AI System Boosts Accuracy in Skin Cancer Diagnosis

Clinical examination is limited by visual similarity between benign and malignant lesions and imperfect diagnostic accuracy.

EMJ Neurology 13 [Supplement 8] 2025

In this article, Ana Suller-Marti, Associate Professor of Neurology, Western University, London, Canada; James Wheless, Professor and…

Optimising CAR-T Cell Therapy in RRMM

The ‘Mastering the Relapsed Refractory Multiple Myeloma (RRMM) Treatment Landscape: Removing Barriers and Unleashing the Potential of…

Evidence on VNS in the Modern DRE Treatment Landscape

Epilepsy affects around 50 million people worldwide. Approximately 30% of them experience drug-resistant epilepsy (DRE), which…

Patient-Reported Outcome Measures, 1 Year After COVID-19

Learn more about the long-term health effects persisting one year after COVID-19 infection, including fatigue, breathlessness…

A collection of illustrated lab equipment

Novo Nordisk taps Replicate’s srRNA platform for obesity

Novo Nordisk partners with Replicate Bioscience in a $550M srRNA deal to develop new therapies for obesity, diabetes and cardiometabolic diseases.

CABANA Trial: Catheter Ablation Benefits Selected Patients with Atrial Fibrillation

Find out who benefits most from catheter ablation for atrial fibrillation according to new research. Keep reading to learn more.

Ten-Year Follow-Up Shows Survival Gains in Prostate Cancer

Discover a study showing lasting survival gains from treatment intensification in prostate cancer.

Vaccination Protects from Asthma and Rhinitis Linked to COVID-19

COVID-19 infection raises risks of asthma, rhinitis, and sinusitis, while vaccination reduces respiratory type-2 inflammatory disease incidence.